Bing Zhang

12.8k citations
131 papers · 3.2k indexed · h-index 32

Bing Zhang

125 papers receiving 3.1k citations

Peers

Bing Zhang
Comparison fields: 5 of 152
  • Catalysis 331
  • Infectious Diseases 572
  • Molecular Medicine 107
  • Biochemistry 129
  • Materials Chemistry 806
Replace Min Sun Yeom with:
Min Sun Yeom South Korea
Vannajan Sanghiran Lee Malaysia
Shinichi Hashimoto Japan
Mingqi Zhao China
Yuanyuan Xu China
Shaohua Huang China
Jinyao Liu China
Wei Xü China
Peter Scholz Germany
Yongqiang Li China
Bing Zhang relative to Min Sun Yeom South Korea Min Sun Yeom's profile →
Citations per field
00.5×1.6×
Min Sun Yeom · 1×
Citations per year

Countries citing papers authored by Bing Zhang

Since Specialization
Citations

This map shows the geographic impact of Bing Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zhang more than expected).

Fields of papers citing papers by Bing Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bing Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zhang. The network helps show where Bing Zhang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Bing Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Bing Zhang Line = papers co-authored together Bing Zhang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20251
2 20250
3 20250
4 20251
5 20240
6 20241
7 20244
8 20236
9 20235
10 2022106
11 20227
12 202027
13
Traditional Chinese medicine-combination therapies utilizing nanotechnology-based targeted delivery systems: a new strategy for antitumor treatment
20194
14 201841
15 201775
16 201656
17 201630
18 201579
19 200975
20 20016

About Bing Zhang

Bing Zhang is a scholar working on Molecular Medicine, Catalysis and Infectious Diseases, having authored 131 papers that have together received 3.2k indexed citations. Recurring topics across this work include Advanced Chemical Physics Studies (12 papers), Tuberculosis Research and Epidemiology (11 papers), Bacterial Genetics and Biotechnology (11 papers), Mass Spectrometry Techniques and Applications (10 papers), Catalytic Processes in Materials Science (9 papers), Catalysis and Oxidation Reactions (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Catalysts for Methane Reforming (6 papers). The work is most often cited by research in Catalysis (331 citations), Infectious Diseases (572 citations) and Molecular Medicine (107 citations). Bing Zhang has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Shuben Li, Zihe Rao, Xiuna Yang, Luke W. Guddat, Jun Zhao, Haitao Yang, Qian Shao, Zhanhu Guo, Jian Yang and Lingjun Chou. Their work appears in journals such as Nature Communications, Protein & Cell, Chemical Physics Letters, Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026